Multidrug-resistant Tuberculosis Detection, Latvia
نویسندگان
چکیده
منابع مشابه
Multidrug-resistant Tuberculosis Detection, Latvia
To improve multidrug-resistant tuberculosis (MDR-TB) detection, we successfully introduced the rpoB gene mutation line probe assay into the national laboratory in Latvia, a country with epidemic MDR-TB. The assay detected rifampin resistance with 91% sensitivity and 96% specificity within 1 to 5 days (vs. 12-47 days for BACTEC).
متن کاملRapid detection of multidrug-resistant tuberculosis.
Transmission of multidrug-resistant strains of Mycobacterium tuberculosis (MDR-TB) presents a serious problem for infection control in hospitals, particularly in the context of co-infection with the human immunodeficiency virus (HIV). We report on the use of molecular genetic tools to allow rapid assessment of samples from patients potentially infected with MDR-TB. Sputum and bronchoalveolar la...
متن کاملRapid detection of multidrug-resistant Mycobacterium tuberculosis
online | memorias.ioc.fiocruz.br Early detection of drug resistance in Mycobacterium tuberculosis isolates allows for appropriate and timely treatment (Martin et al. 2008). There are many welldefined phenotypic methods for testing the drug susceptibility of M. tuberculosis. The proportion method, performed on Löwenstein-Jensen and 7H10 or 7H11 agar media, is recommended as a reference method. H...
متن کاملAudiological Evaluation of Patients Taking Kanamycin for Multidrug Resistant Tuberculosis
Introduction: The incidence of multidrug resistant tuberculosis is increasing in developing countries. Aminoglycosides are an integral part of second-line drugs, however ototoxicity is a major limitation for their use. This study aims to determine the extent of hearing loss in patients taking one of the commonly prescribed drugs for Multidrug resistant tuberculosis (MDR-TB), Kanamycin, at a Gov...
متن کاملTreatment outcome of multidrug/extensively drug-resistant tuberculosis in Latvia, 2000-2004.
In the present study, we characterised drug-resistance patterns, compared treatment outcome between extensively and nonextensively drug-resistant tuberculosis (non-XDR-TB) cases, and assessed risk factors for poor outcome in a high-prevalence country that screens all TB patients for first-line anti-TB drug resistance. We reviewed drug susceptibility test results among all pulmonary TB cases in ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Emerging Infectious Diseases
سال: 2005
ISSN: 1080-6040,1080-6059
DOI: 10.3201/eid1109.041236